Related Experiment Video
Updated: Aug 5, 2026

Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning
Published on: November 19, 2018
Computer-assisted discrimination among malignant lymphomas and leukemia using immunophenotyping, intelligent image
D J Foran1, D Comaniciu, P Meer
1Center for Biomedical Imaging & Informatics, UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
Insights
This study introduces a novel computer-assisted system for diagnosing hematologic malignancies. The system accurately classifies disorders like lymphoma and leukemia, improving upon traditional microscopy methods.
Area of Science:
- Hematology
- Medical Informatics
- Computational Pathology
Background:
- Traditional diagnosis of hematologic malignancies relies on subjective light microscopy, leading to potential misclassifications.
- Subtle cellular differences in conditions like malignant lymphomas and leukemia contribute to false negatives in manual evaluations.
Purpose of the Study:
- To develop and evaluate a distributed clinical decision support system for distinguishing hematologic malignancies.
- To enhance diagnostic accuracy and facilitate remote collaboration among medical professionals.
Main Methods:
- Development of a hybrid system integrating a telemicroscopy platform and an intelligent image repository.
- Remote control of robotic microscopes and real-time digital specimen broadcasting via JAVA-based software.
- Implementation of a database search engine for retrieving similar spectral and spatial profiles to aid diagnosis.
Main Results:
- The system correctly classified hematologic malignancies in over 83% of cases studied.
- Demonstrated successful discrimination among three lymphoproliferative disorders and healthy cells.
- System performance was validated through rigorous statistical analysis and comparison with human expert diagnoses.
Conclusions:
- The developed system offers a promising computer-assisted approach to improve the accuracy of hematologic malignancy diagnosis.
- The distributed nature of the system enables effective remote consultation and decision support, overcoming geographical barriers.
- This technology has the potential to reduce diagnostic errors and enhance patient care in hematology.
Abstract:
The process of discriminating among pathologies involving peripheral blood, bone marrow, and lymph node has traditionally begun with subjective morphological assessment of cellular materials viewed using light microscopy. The subtle visible differences exhibited by some malignant lymphomas and leukemia, however, give rise to a significant number of false negatives during microscopic evaluation by medical technologists. We have developed a distributed, clinical decision support prototype for distinguishing among hematologic malignancies. The system consists of two major components, a distributed telemicroscopy system and an intelligent image repository. The hybrid system enables individuals located at disparate clinical and research sites to engage in interactive consultation and to obtain computer-assisted decision support. Software, written in JAVA, allows primary users to control the specimen stage, objective lens, light levels, and focus of a robotic microscope remotely while a digital representation of the specimen is continuously broadcast to all session participants. Primary user status can be passed as a token. The system features shared graphical pointers, text messaging capability, and automated database management. Search engines for the database allow one to automatically identify and retrieve images, diagnoses, and correlated clinical data of cases from a "gold standard" database which exhibit spectral and spatial profiles which are most similar to a given query image. The system suggests the most likely diagnosis based on majority logic of the retrieved cases. The system was used to discriminate among three lymphoproliferative disorders and healthy cells. The system provided the correct classification in more than 83% of the cases studied. System performance was evaluated using rigorous statistical assessment and by comparison with human observers.
More Related Videos
07:52Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
Published on: January 9, 2019
07:32Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software
Published on: April 12, 2024